Brief: Cytek Biosciences Q3 Revenue USD 51.5 Million Vs. IBES Estimate USD 50.7 Million
05/11/2024 21:05
Nov 05 (Reuters) - Cytek Biosciences Q3 adjusted EBITDA USD 7.627 million. * Q3 net income USD 941 thousand vs. IBES estimate USD -3 million * Q3 pretax profit USD 157 thousand vs. IBES estimate USD -3.33 million * Q3 adjusted gross margin 60% * outlook FY revenue USD 203-210 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million